1,600 new cases of anal cancer each year, 2017-2019 average, UK.
Deaths
480 deaths from anal cancer, 2021-2023, UK.
Survival
52% survive anal cancer for 10 or more years, 2013-2017, England
Preventable cases
91% of anal cancer cases are preventable, UK, 2015
There are around 1,600 new anal cancer cases in the UK every year, that's more than 4 every day (2017-2019).
Anal cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017-2019).
In females in the UK, anal cancer is not among the 20 most common cancers, with around 1,000 new cases every year. That's 1% of all new female cancer cases in the UK (2017-2019).
In males in the UK, anal cancer is not among the 20 most common cancers, with around 530 new cases every year. That's less than 1% of all new male cancer cases in the UK (2017-2019).
Incidence rates for anal cancer in the UK are highest in people aged 80 to 84 (2017-2019).
Each year a quarter (25%) of all new anal cancer cases in the UK are diagnosed in people aged 75 and over (2017-2019).
Since the early 1990s, anal cancer incidence rates have increased by almost four-fifths (78%) in the UK. Rates in females have around doubled (118%), and rates in males have increased by almost a third (30%) (2017-2019).
Over the last decade, anal cancer incidence rates have increased by almost a third (31%) in the UK. Rates in females have increased by more than two-fifths (42%), and rates in males have increased by a seventh (14%) (2017-2019).
Anal cancer incidence rates are projected to rise by 14% in the UK between 2023-2025 and 2038-2040.
There could be around 2,400 new cases of anal cancer every year in the UK by 2038-2040, projections suggest.
Anal cancer incidence rates in England in females are 60% higher in the most deprived quintile compared with the least, and in males are 89% higher in the most deprived quintile compared with the least (2013-2017).
Around 260 cases of anal cancer each year in England are linked with deprivation (around 160 in females and around 100 in males).
An estimated 6,700 people who had previously been diagnosed with anal cancer were alive in the UK at the end of 2010.
There are around 480 anal cancer deaths in the UK every year, that's more than 1 every day (2021-2023).
Anal cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2021-2023).
In females in the UK, anal cancer is not among the 20 most common causes of cancer death, with around 290 deaths every year. That's less than 1% of all female cancer deaths in the UK (2021-2023).
In males in the UK, anal cancer is not among the 20 most common causes of cancer death, with around 190 deaths every year. That's less than 1% of all male cancer deaths in the UK (2021-2023).
Mortality rates for anal cancer in the UK are highest in people aged 90+ (2021-2023).
Each year almost half (45%) of anal cancer deaths in the UK are in people aged 75 and over (2021-2023).
Since the late 1970s, anal cancer mortality rates have increased by almost nine-tenths (87%) in the UK. Rates in females have around doubled (119%), and rates in males have increased by almost three-fifths (57%) (2021-2023).
Over the last decade, anal cancer mortality rates have increased by around a third (34%) in the UK. Rates in females have increased by around a third (34%), and rates in males have increased by almost two-fifths (38%) (2021-2023).
Mortality rates for bowel cancer and anal cancer combined are generally lower in people of non-White minority ethnicity, compared with the White ethnic group, in England and Wales (2017-2019). See the publication Mortality from leading causes of death by ethnic group, England and Wales.
Anal cancer mortality rates are projected to rise by 45% in the UK between 2023-2025 and 2038-2040.
There could be around around 950 deaths of anal cancer every year in the UK by 2038-2040, projections suggest.
Mortality rates for lower GI cancer (which includes anal cancer) in the UK in females are 25% higher in the most deprived quintile compared with the least, and rates in males are 31% higher in the most deprived quintile compared with the least.
Around 1,700 deaths from lower GI cancer each year in the UK are linked with deprivation (around 650 in females, and around 1,000 in males).
More than 1 in 2 (52.2%) people diagnosed with anal cancer in England survive their disease for ten years or more, it is predicted (2013-2017).
Anal cancer ten-year survival in England is higher in females than males (2013-2017).
Around 7 in 10 (71.2%) people in England diagnosed with anal cancer aged 15-44 survive their disease for ten years or more, compared with around a third (32.3%) of people diagnosed aged 75-99 (2013-2017).
Almost two-thirds (63.3%) of people in England diagnosed with anal cancer in the least deprived group survive their disease for five years or more, compared with 6 in 10 (60.4%) people in the most deprived group (2016-2020).
For anal cancer, like other cancer sites, survival trends reflect a combination of changes in treatment and stage distribution. These factors themselves can vary by age, sex and deprivation.
Further survival statistics by stage can be found on the Early Diagnosis Data Hub and information on treatments for cancer can be found here.
A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
1 in 280 UK females and 1 in 720 UK males will be diagnosed with anal cancer in their lifetime (born in 1961).
91% of anal cancer cases in the UK are preventable.
91% of anal cancer cases in the UK are caused by infections.
See our Early Diagnosis Data Hub; for statistics on routes to diagnosis and screening uptake/coverage (for relevant cancer types)
For the most up-to-date statistics on early diagnosis and other metrics see our publications
Anal cancer treatment
See our Treatment Data Hub which gathers information and statistics across a number of cancer treatment measures, including proportions of treatments given over time and detailed data on radiotherapy delivery. You can also ”view overviews of many national cancer site audits, split by site and country.
Statistics by cancer type
View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ.
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.
